"Rescue" platelet GP IIb/IIIa inhibitor therapy in percutaneous coronary intervention: bailing out of a sunken ship

J Invasive Cardiol. 2000 Oct;12(10):502-4.

Authors

D E Kandzari¹, J E Tcheng, R A Harrington, M H Sketch Jr

Affiliation

¹ Division of Cardiology, P.O. Box 31203, Duke University Medical Center, Durham, NC 27710, USA. kandz002@onyx.dcri.duke.edu

PMID: 11022208

No abstract available

Publication types

Comment

MeSH terms

Abciximab
Angioplasty, Balloon, Coronary / adverse effects*
Angioplasty, Balloon, Coronary / methods
Antibodies, Monoclonal / administration & dosage*
Emergency Treatment
Female
Follow-Up Studies
Humans
Immunoglobulin Fab Fragments / administration & dosage*
Male
Myocardial Infarction / drug therapy*
Myocardial Infarction / mortality
Myocardial Infarction / therapy
Myocardial Ischemia / etiology
Myocardial Ischemia / prevention & control*
Platelet Aggregation Inhibitors / administration & dosage*
Platelet Glycoprotein GPIIb-IIIa Complex / drug effects*
Randomized Controlled Trials as Topic
Survival Rate

Substances

Antibodies, Monoclonal
Immunoglobulin Fab Fragments
Platelet Aggregation Inhibitors
Platelet Glycoprotein GPIIb-IIIa Complex
Abciximab